Deskside with Dr. Dan FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma Dr. Dan explains the FDA approval of a new treatment combination for Multiple Myeloma patients. Article from February 2021. Gryt Health October 20, 2022
Deskside with Dr. Dan FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma Dr. Dan, Gryt Health’s Chief Medical Officer breaks down the takeaways of this new approval from January 2021. Gryt Health July 7, 2022
Programs Multiple Myeloma Meetup: Program Recap (What It Is & Treatment Info) On March 24, 2021, GRYT Health partnered with the Multiple Myeloma Research Foundation (MMRF) to host a Multiple Myeloma Meetup. This is the program summary. Christian Bullock May 16, 2022